Sartorius Aktiengesellschaft (0NIQ.L)
EUR 172.6
(-1.6%)
EUR 172.6
(-1.6%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 5.02 Billion EUR | 168.08% |
| 2022 | 1.87 Billion EUR | 13.63% |
| 2021 | 1.64 Billion EUR | -9.71% |
| 2020 | 1.82 Billion EUR | 122.14% |
| 2019 | 822.15 Million EUR | -6.42% |
| 2018 | 878.53 Million EUR | 1.0% |
| 2017 | 869.83 Million EUR | 100.87% |
| 2016 | 433.03 Million EUR | 18.3% |
| 2015 | 366.04 Million EUR | -3.33% |
| 2014 | 378.66 Million EUR | 0.74% |
| 2013 | 375.87 Million EUR | 55.57% |
| 2012 | 241.6 Million EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 4.29 Billion EUR | -2.91% |
| 2024 Q2 | 4.42 Billion EUR | -6.9% |
| 2024 Q1 | 4.74 Billion EUR | -3.27% |
| 2023 Q4 | 4.9 Billion EUR | -0.21% |
| 2023 FY | 4.9 Billion EUR | 162.0% |
| 2023 Q1 | 2.13 Billion EUR | 13.87% |
| 2023 Q2 | 2.17 Billion EUR | 1.71% |
| 2023 Q3 | 4.91 Billion EUR | 126.69% |
| 2022 Q3 | 1.58 Billion EUR | -2.17% |
| 2022 Q1 | 1.64 Billion EUR | -0.16% |
| 2022 FY | 1.87 Billion EUR | 13.63% |
| 2022 Q2 | 1.62 Billion EUR | -1.54% |
| 2022 Q4 | 1.87 Billion EUR | 18.16% |
| 2021 Q4 | 1.64 Billion EUR | -1.99% |
| 2021 Q2 | 1.67 Billion EUR | 0.0% |
| 2021 FY | 1.64 Billion EUR | -9.71% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q3 | 1.68 Billion EUR | 0.26% |
| 2020 Q4 | 1.89 Billion EUR | -6.37% |
| 2020 Q3 | 2.02 Billion EUR | 20.96% |
| 2020 FY | 1.82 Billion EUR | 122.14% |
| 2020 Q1 | 905.2 Million EUR | 2.75% |
| 2020 Q2 | 1.67 Billion EUR | 84.54% |
| 2019 Q3 | 917.09 Million EUR | -5.31% |
| 2019 FY | 822.15 Million EUR | -6.42% |
| 2019 Q4 | 880.94 Million EUR | -3.94% |
| 2019 Q2 | 968.5 Million EUR | 6.03% |
| 2019 Q1 | 913.4 Million EUR | 2.1% |
| 2018 Q2 | 910.8 Million EUR | 1.12% |
| 2018 Q3 | 913.7 Million EUR | 0.32% |
| 2018 Q1 | 900.7 Million EUR | 1.5% |
| 2018 FY | 878.53 Million EUR | 1.0% |
| 2018 Q4 | 894.64 Million EUR | -2.09% |
| 2017 Q2 | 924.5 Million EUR | 71.33% |
| 2017 FY | 869.83 Million EUR | 100.87% |
| 2017 Q4 | 887.39 Million EUR | -3.97% |
| 2017 Q3 | 924.1 Million EUR | -0.04% |
| 2017 Q1 | 539.6 Million EUR | 19.39% |
| 2016 Q1 | 395.6 Million EUR | 8.07% |
| 2016 Q4 | 451.94 Million EUR | -15.13% |
| 2016 Q3 | 532.5 Million EUR | 2.42% |
| 2016 Q2 | 519.9 Million EUR | 31.42% |
| 2016 FY | 433.03 Million EUR | 18.3% |
| 2015 Q1 | 332.79 Million EUR | -12.11% |
| 2015 FY | 366.04 Million EUR | -3.33% |
| 2015 Q4 | 366.04 Million EUR | 12.21% |
| 2015 Q3 | 326.2 Million EUR | -4.68% |
| 2015 Q2 | 342.2 Million EUR | 2.82% |
| 2014 Q2 | 377.8 Million EUR | 2.52% |
| 2014 Q1 | 368.5 Million EUR | -1.96% |
| 2014 FY | 378.66 Million EUR | 0.74% |
| 2014 Q4 | 378.66 Million EUR | 0.9% |
| 2014 Q3 | 375.3 Million EUR | -0.66% |
| 2013 Q1 | 235.2 Million EUR | -2.65% |
| 2013 Q3 | 336.9 Million EUR | 37.9% |
| 2013 Q4 | 375.87 Million EUR | 11.57% |
| 2013 Q2 | 244.3 Million EUR | 3.87% |
| 2013 FY | 375.87 Million EUR | 55.57% |
| 2012 Q4 | 241.6 Million EUR | 0.0% |
| 2012 FY | 241.6 Million EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Cegedim SA | 188.54 Million EUR | -2564.23% |
| Guerbet SA | 360.51 Million EUR | -1293.356% |
| Nexus AG | 15.43 Million EUR | -32438.541% |
| Bastide Le Confort Médical SA | 291.04 Million EUR | -1625.935% |
| Revenio Group Oyj | 10.05 Million EUR | -49883.085% |
| Drägerwerk AG & Co. KGaA | 257.71 Million EUR | -1849.199% |
| LNA Santé SA | 341.16 Million EUR | -1372.4% |
| Siemens Healthineers AG | 436 Million EUR | -1052.133% |
| Medios AG | 14.65 Million EUR | -34177.039% |
| Equasens Société anonyme | 39.51 Million EUR | -12611.744% |
| Stratec SE | 80.8 Million EUR | -6116.955% |